news

Oct 20 2014
Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences

Oct 16 2014
ContraVir Pharmaceuticals Selects Pharmaceutical Product Development to Manage Phase 2b Study of Lead Antiviral FV-100 for Treating Shingles

Oct 15 2014
Synthetic Biologics Appoints Prominent Gastrointestinal (GI) Key Opinion Leaders to Irritable Bowel Syndrome (IBS) Clinical Advisory Board

 

events

 

spotlight